Examinant per Autoria "Arriola Aperribay, Edurne"
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Acquired mechanisms of resistance to osimertinib-the next challenge(MDPI, 2022) Ríos-Hoyo, Alejandro; Moliner Jiménez, Laura; Arriola Aperribay, Edurne
Ítem Accés Obert Addition of immune checkpoint inhibitors to chemotherapy vs chemotherapy alone as first-line treatment in extensive-stage small-cell lung carcinoma: a systematic review and meta-analysis(Springer, 2022) Arriola Aperribay, Edurne; González Cao, María; Domine, Manuel; De Castro, Javier; Cobo, Manuel; Bernabé, Reyes; Navarro, Alejandro; Sullivan, Ivana; Trigo, José Manuel; Mosquera, Joaquín; Crama, Leonardo; Isla, Dolores
Ítem Accés Obert An open-label, multicenter, randomized, phase II study of Cisplatin and Pemetrexed with or without Cixutumumab (IMC-A12) as a first-line therapy in patients with advanced nonsquamous non-small cell lung cancer.(Elsevier, 2017) Novello, Silvia; Scagliotti, Giorgio; De Castro, Gilberto; Kiyik, Murat; Kowalyszyn, Rubén; Deppermann, Karl-Matthias; Arriola Aperribay, Edurne; Bosquee, Lionel; Novosiadly, Ruslan D.; Nguyen, Tuan S.; Forest, Amelie; Tang, Shande; Kambhampati, Siva Rama Prasad; Cosaert, Jan; Reck, Martin
Ítem Accés Obert Assessment of a new ROS1 immunohistochemistry clone (SP384) for the identification of ROS1 rearrangements in patients with non-small cell lung carcinoma: the ROSING study(Elsevier, 2019) Conde, Esther; Pijuan Andujar, Lara; Salido Galeote, Marta; Arriola Aperribay, Edurne; Company, Amparo; Lopez-Rios, Fernando
Ítem Accés Obert CD33 expression on peripheral blood monocytes predicts efficacy of anti-PD-1 immunotherapy against non-small cell lung cancer(Frontiers, 2022) Olingy, Claire; Alimadadi, Ahmad; Araujo, Daniel J.; Barry, David; Gutiérrez, Norma; Werbin, Max Hardy; Arriola Aperribay, Edurne; Patel, Sandip Pravin; Ottensmeier, Christian H.; Dinh, Huy Q.; Hedrick, Catherine C.
Ítem Accés Obert CD8 T-cell-mediated cerebellitis directed against Purkinje cell antigen after ipilimumab for small cell lung cancer(Wiley, 2022) Hardwick, Marc; Nolan, Luke; Nicoll, James A.R.; Jogai, Sanjay; Arriola Aperribay, Edurne; Joseph-Pietras, Debora; Norman, Jeanette; Ottensmeier, Christian H.H.; Galea, Ian
Ítem Accés Obert Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain(BioMed Central, 2018) Arriola Aperribay, Edurne; García Gómez, Ramón; Diz Tain, Pilar; Majem, Margarita; Martínez Aguillo, Maite; Valdivia, Javier; Paredes, Alfredo; Sánchez-Torres, José Miguel; Peralta Muñoz, Sergio; Barneto, Isidoro; Gutierrez, Vanesa; Andrade Santiago, Jesús Manuel; Aparisi, Francisco; Isla, Dolores; Ponce, Santiago; Vicente Baz, David; Artal, Angel; Amador, Mariluz; Provencio, Mariano
Ítem Accés Obert Comparison of different methods for defining hyperprogressive disease in NSCLC(Elsevier, 2020) Rocha, Pedro P.; Ramal, Didac; Ripoll, Enric; Moliner, Laura; Corbera-Lloret, Alex; Hardy-Werbin, Max; Orrillo, Mayra; Taus García, Álvaro; Zuccarino, Flavio; Gibert Fernandez, Joan, 1988-; Perera Bel, Júlia; Casadevall Aguilar, David; Arriola Aperribay, Edurne
Ítem Accés Obert Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS(SpringerOpen, 2018) Arriola Aperribay, Edurne; Paredes, Alfredo; García Gomez, R.; Diz Tain, Pilar; Constenla, M.; García Girón, C.; Márquez, G.; Reck, Martin; López Vivanco, G.
Ítem Accés Obert Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer(Frontiers, 2023) Clavé Safont, Sergi; Salido Galeote, Marta; Gibert Fernandez, Joan, 1988-; Hardy-Werbin, Max; Rocha, Pedro P.; Riera, Xènia; Torres, Erica; Taus García, Álvaro; Pijuan Andujar, Lara; Bellosillo Paricio, Beatriz; Arriola Aperribay, Edurne
Ítem Accés Obert ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study.(Elsevier, 2006) Reck, Martin; Hagiwara, Koichi; Han, Baohui; Tjulandin, Sergei; Grohé, Christian; Yokoi, Takashi; Morabito, Alessandro; Novello, Silvia; Arriola Aperribay, Edurne; Molinier, Olivier; McCormack, Rose; Ratcliffe, Marianne; Normanno, Nicola
Ítem Accés Obert Diffuse dermal mucinosis secondary to colony-stimulating factor 1 receptor monoclonal antibody treatment: A novel and peculiar drug-induced diffuse cutaneous mucinosis(Wiley, 2021) Olmos Alpiste, Ferran; Segura Tigell, Sonia; Tomás-Velázquez, Alejandra; Aguado, Leyre; España, Agustín; Arriola Aperribay, Edurne; Martín-Algarra, Salvador; Barranco Sanz, Luis Carlos; Lloreta, Josep, 1958-; Pujol Vallverdú, Ramon Maria
Ítem Accés Obert EGFR and KRAS mutations in the non-tumoral lung. Prognosis in patients with adenocarcinoma(MDPI, 2019) Chalela Rengifo, Roberto José, 1985-; Bellosillo Paricio, Beatriz; Curull Serrano, Víctor; Longarón Rozalen, Raquel; Pascual Guàrdia, Sergi, 1979-; Badenes Bonet, Diana, 1987-; Arriola Aperribay, Edurne; Sánchez-Font, Albert; Pijuan Andujar, Lara; Gea Guiral, Joaquim
Ítem Accés Obert Expert consensus on the management of adverse events of Lorlatinib in the treatment of ALK+ advanced non-small cell lung cancer(Springer, 2024) Arriola Aperribay, Edurne; De Castro, Javier; García-Campelo, Rosario; Bernárdez, Beatriz; Bernabé, Reyes; Bruna, Jordi; Dómine, Manuel; Isla, Dolores; Juan Vidal, Óscar; López-Fernández, Teresa; Nadal, Ernest; Rodríguez-Abreu, Delvys; Vares, María; Asensio, Úrsula; García, Luis F.; Felip, Enriqueta
Ítem Accés Obert Healthcare resource utilization in advanced non-small-cell lung cancer: post hoc analysis of the randomized phase 3 REVEL study(SpringerOpen, 2021) Garon, Edward B.; Winfree, Katherine B.; Molife, Cliff; Cui, Zhanglin Lin; Arriola Aperribay, Edurne; Levy, Benjamin; Mekhail, Tarek; Pérol, Maurice
Ítem Accés Obert High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients(Impact Journal, 2014) Cañadas, Israel; Taus, Álvaro; González, Iria; Villanueva, Xavie; Gimeno, Javier; Pijuan, Lara; Dómine, Manuel; Sánchez-Font, Albert; Vollmer, Ivan; Menéndez, Silvia; Arpí, Oriol; Mojal, Sergio; Rojo, Federico; Rovira, Ana; Albanell, Joan; Arriola Aperribay, Edurne
Ítem Accés Obert Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic(Frontiers, 2023) Rios-Hoyo, Alejandro; Arriola Aperribay, Edurne
Ítem Accés Obert Immunotherapy is here to stay: a new treatment paradigm in lung cancer(Elsevier, 2019) Rocha, Pedro P.; Arriola Aperribay, Edurne
Ítem Accés Obert Is there a role for epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor wild-type non-small cell lung cancer?(Baishideng Publishing Group, 2015) Arriola Aperribay, Edurne; Taus García, Álvaro; Casadevall Aguilar, David
Ítem Accés Obert MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC).(Impact Journals, 2015) Casadevall Aguilar, David; Gimeno Beltran, Javier; Clavé Safont, Sergi; Taus García, Álvaro; Pijuan Andujar, Lara; Arumí de Dios, Miriam; Lorenzo Perez, Marta; Menendez Romero, Silvia; Cañadas Castillo, Israel, 1984-; Albanell Mestres, Joan; Serrano Figueras, Sergi; Espinet Solà, Blanca; Salido Galeote, Marta; Arriola Aperribay, Edurne